Neuralink, Elon Musk's brain-chip startup, is being valued at as high as $42 billion in recent secondary market transactions, according to correspondence seen by Business Insider. The valuation reflects surging demand for a piece of anything related to Musk, who is nearing trillionaire status.
Secondary market transactions involve existing shares being sold by early investors or employees to new investors, often at prices that imply a higher valuation than the company's last primary funding round. Neuralink's last known primary valuation was around $5 billion in 2023, though the company has not publicly confirmed any recent funding rounds.
The $42 billion figure is based on private correspondence and may not represent official company valuation. Neuralink has not commented on the secondary market activity. The company is focused on developing brain-computer interfaces, with initial human trials approved by the U.S. Food and Drug Administration in 2023.
